HALO
Halozyme Therapeutics, Inc.
stockNASDAQ
At CloseNov 13, 2026 3:59:59 PM EST
100.30USD-0.368%(-0.37)2,276,201
After-hoursNov 13, 2026 4:02:30 PM EST
99.99USD-0.312%(-0.31)
HALO Financials
In Q3 FY 2026 (ended ), Halozyme Therapeutics, Inc. (HALO) reported revenue of $492.97M, net income of $247.05M, operating cash flow of $258.27M, and assets of $3.47B (filed ).
Loading financial statements…